1. Home
  2. BMEA vs RIV Comparison

BMEA vs RIV Comparison

Compare BMEA & RIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BMEA
  • RIV
  • Stock Information
  • Founded
  • BMEA 2017
  • RIV 2015
  • Country
  • BMEA United States
  • RIV United States
  • Employees
  • BMEA N/A
  • RIV N/A
  • Industry
  • BMEA Biotechnology: Pharmaceutical Preparations
  • RIV Finance Companies
  • Sector
  • BMEA Health Care
  • RIV Finance
  • Exchange
  • BMEA Nasdaq
  • RIV Nasdaq
  • Market Cap
  • BMEA 275.6M
  • RIV 267.3M
  • IPO Year
  • BMEA 2021
  • RIV N/A
  • Fundamental
  • Price
  • BMEA $11.24
  • RIV $12.78
  • Analyst Decision
  • BMEA Buy
  • RIV
  • Analyst Count
  • BMEA 13
  • RIV 0
  • Target Price
  • BMEA $36.33
  • RIV N/A
  • AVG Volume (30 Days)
  • BMEA 1.1M
  • RIV 87.6K
  • Earning Date
  • BMEA 11-01-2024
  • RIV 01-01-0001
  • Dividend Yield
  • BMEA N/A
  • RIV 12.85%
  • EPS Growth
  • BMEA N/A
  • RIV N/A
  • EPS
  • BMEA N/A
  • RIV N/A
  • Revenue
  • BMEA N/A
  • RIV N/A
  • Revenue This Year
  • BMEA N/A
  • RIV N/A
  • Revenue Next Year
  • BMEA N/A
  • RIV N/A
  • P/E Ratio
  • BMEA N/A
  • RIV N/A
  • Revenue Growth
  • BMEA N/A
  • RIV N/A
  • 52 Week Low
  • BMEA $3.61
  • RIV $9.63
  • 52 Week High
  • BMEA $22.74
  • RIV $12.43
  • Technical
  • Relative Strength Index (RSI)
  • BMEA 64.18
  • RIV 54.19
  • Support Level
  • BMEA $10.35
  • RIV $12.62
  • Resistance Level
  • BMEA $12.30
  • RIV $12.90
  • Average True Range (ATR)
  • BMEA 0.93
  • RIV 0.13
  • MACD
  • BMEA -0.01
  • RIV -0.03
  • Stochastic Oscillator
  • BMEA 47.26
  • RIV 46.76

About BMEA Biomea Fusion Inc.

Biomea Fusion Inc is a preclinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of irreversible small molecule drugs to treat patients with genetically defined cancers. The company's product candidate, BMF-219, is designed to be an orally bioavailable, potent and selective irreversible inhibitor of menin, an important transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers.

About RIV RiverNorth Opportunities Fund Inc.

Rivernorth Opportunities Fund Inc is a diversified, closed-end management investment company. The fund's investment objective is total return consisting of capital appreciation and current income.

Share on Social Networks: